Inclusive of all taxes
Tenofovir Disoproxil Fumarate Tablets IP 300 mg is a high-quality pharmaceutical formulation specifically designed for managing supplements-related conditions. Manufactured under stringent WHO-GMP compliant facilities, these tablets guarantee precise dosing, consistent therapeutic efficacy, and compliance with international pharmaceutical regulations. Ideal for institutional supply and export markets, the product is supplied in export-grade blister or strip packs, ensuring product integrity during transportation and storage. Each tablet contains 300 mg of Tenofovir Disoproxil Fumarate, an active pharmaceutical ingredient known for its reliability in clinical use. This product is manufactured by IndiGlobal Exports and is suitable for use in hospitals, retail pharmacies, and healthcare facilities globally. Adhering to Pharmacopoeial standards (IP/USP), this formulation supports effective patient management of supplements conditions, ensuring reliable therapeutic outcomes with safety and quality.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Tenofovir Disoproxil Fumarate 300 mg |
| Dosage Form | Tablet |
| Indication | Management of supplements-related clinical conditions |
| Packaging | Export-grade blister or strip packs |
| Manufacturing Standards | WHO-GMP compliant facilities |
| Quality Compliance | Meets IP and USP pharmacopoeial standards |
| Therapeutic Performance | Consistent and reliable efficacy |
| Manufacturer | IndiGlobal Exports |
| Suitable Markets | Regulated and semi-regulated international pharmaceutical markets |
| Shelf Life | As per regulatory standards |
| Attributes | Description |
|---|---|
| Category | Supplements |
| Formulation | Tablet |
| Active Pharmaceutical Ingredient | Tenofovir Disoproxil Fumarate |
| Strength | 300 mg per tablet |
| Packaging Type | Blister pack / Strip pack suitable for export |
| Manufacturing Facility | WHO-GMP certified |
| Pharmacopoeial Standards | IP/USP compliant |
| Intended Use | Clinical treatment of supplements-related conditions |
| Shelf Life | Conforms to regulatory requirements |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, the tablets are manufactured following WHO-GMP guidelines in export-grade blister or strip packaging, ensuring compliance with international pharmaceutical regulations and suitability for global markets.
Yes, Tenofovir Disoproxil Fumarate Tablets IP 300 mg meets both Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) quality standards, ensuring consistent efficacy and safety.
Absolutely, the product's manufacturing and quality control processes comply with international guidelines, making it appropriate for both regulated and semi-regulated markets.
These tablets are available in export-grade blister packs or strip packs, designed to maintain product stability during bulk shipment and facilitate easy dispensing.
They are formulated specifically for managing supplements-related clinical conditions, offering healthcare providers a reliable dosage form for patient treatment.
Brand: indiglobal exports
Country Of Origin: India
Tenofovir Disoproxil Fumarate Tablets IP 300 mg is a pharmaceutical product indicated for supplements treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Tenofovir Disoproxil Fumarate Tablets IP 300 mg is developed for the effective management of supplements conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with supplements indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
